Structures by: Krivopalov V. P.
Total: 25
Dichlorido(4-(1H-pyrazol-1-yl)-2-(pyridin-2-yl)-6-methylpyrimidine)copper
C13H11Cl2CuN5
Inorganica Chimica Acta (2013) 395, 95-103
a=9.233(2)Å b=9.310(3)Å c=16.356(5)Å
α=90.00° β=92.914(13)° γ=90.00°
Dichlorido(4-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(pyridin-2-yl)-6- methylpyrimidine)copper
C15H15Cl2CuN5
Inorganica Chimica Acta (2013) 395, 95-103
a=9.1063(6)Å b=12.5987(8)Å c=14.4209(9)Å
α=96.150(3)° β=90.778(3)° γ=92.127(3)°
Dodekachloridotetrakis(4-(1H-pyrazol-1-yl)-2-(pyridin-2-yl)-6- methylpyrimidine)heptacopper(2+) hexachloridodicuprate(2-)
C52H44Cl12Cu7N202,Cl6Cu22
Inorganica Chimica Acta (2013) 395, 95-103
a=9.743(5)Å b=13.755(6)Å c=15.437(8)Å
α=65.086(11)° β=82.287(11)° γ=87.008(15)°
Tetrachlorido(4-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(pyridin-2-yl)-6- methylpyrimidine)dicopper
C15H15Cl4Cu2N5
Inorganica Chimica Acta (2013) 395, 95-103
a=8.6809(4)Å b=11.9593(5)Å c=18.8121(8)Å
α=90.00° β=101.0240(10)° γ=90.00°
Octachloridobis(4-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(pyridin-2-yl)-6- methylpyrimidine)tetracopper
C30H30Cl8Cu4N10
Inorganica Chimica Acta (2013) 395, 95-103
a=20.1333(6)Å b=11.6425(6)Å c=17.1806(6)Å
α=90.00° β=112.518(2)° γ=90.00°
Dichlorido(4-(1H-pyrazol-1-yl)-2-(pyridin-2-yl)-6- methylpyrimidine)copper hemihydrate
C13H11Cl2CuN5,HO0.50
Inorganica Chimica Acta (2013) 395, 95-103
a=13.0700(13)Å b=10.2542(10)Å c=22.668(2)Å
α=90.00° β=105.063(3)° γ=90.00°
C48H46Cl2MnN10,C2H6O,H2O
C48H46Cl2MnN10,C2H6O,H2O
Dalton transactions (Cambridge, England : 2003) (2018) 47, 5 1657-1665
a=11.6451(3)Å b=17.7149(5)Å c=23.7054(7)Å
α=90° β=101.5090(10)° γ=90°
C48H46Cl2MnN10,C3H6O
C48H46Cl2MnN10,C3H6O
Dalton transactions (Cambridge, England : 2003) (2018) 47, 5 1657-1665
a=19.279(4)Å b=13.195(4)Å c=20.968(7)Å
α=90° β=115.383(17)° γ=90°
Bis(2-(3,5-dimethyl-1H-pyrazol-1-yl)-4-methyl-6-(pyridin-2-yl)pyrimidine)iron(II)tetrafluoroborate ethanol solvate (1:1)
C30H30N10Fe2,2(BF41),C2H6O
Dalton transactions (Cambridge, England : 2003) (2018) 47, 29 9585-9591
a=8.8221(5)Å b=14.8811(7)Å c=27.4419(15)Å
α=90° β=93.482(2)° γ=90°
C42H38BrCuN5P
C42H38BrCuN5P
Dalton transactions (Cambridge, England : 2003) (2014) 43, 7 2953-2960
a=11.2558(4)Å b=13.1040(5)Å c=13.3930(5)Å
α=69.8400(10)° β=79.4400(10)° γ=82.6460(10)°
C42H38ClCuN5P
C42H38ClCuN5P
Dalton transactions (Cambridge, England : 2003) (2014) 43, 7 2953-2960
a=11.1677(4)Å b=13.1184(7)Å c=13.3150(7)Å
α=69.3970(10)° β=79.4040(10)° γ=82.5140(10)°
C42H38CuIN5P
C42H38CuIN5P
Dalton transactions (Cambridge, England : 2003) (2014) 43, 7 2953-2960
a=10.5244(3)Å b=17.7367(7)Å c=20.6698(9)Å
α=90.00° β=104.1900(10)° γ=90.00°
Bis[4-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(pyridin-2-yl)-6-methylpyrimidine] iron(II) ditetrafluoroborate hydrate
C30H30FeN102,(BF41)2,0.11(H2O)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 10 3906-3910
a=12.035(2)Å b=19.525(4)Å c=15.481(2)Å
α=90.00° β=108.034(12)° γ=90.00°
C25H18N4O
C25H18N4O
Dalton transactions (Cambridge, England : 2003) (2015) 45, 2 515-524
a=7.9801(7)Å b=18.5685(19)Å c=26.854(3)Å
α=90.00° β=90.00° γ=90.00°
C46H42ClCuN10O2,Cl2Cu
C46H42ClCuN10O2,Cl2Cu
Dalton transactions (Cambridge, England : 2003) (2015) 45, 2 515-524
a=9.1159(2)Å b=13.6244(3)Å c=18.4950(4)Å
α=74.0080(10)° β=85.5160(10)° γ=89.2250(10)°
C23H21N5O
C23H21N5O
Dalton transactions (Cambridge, England : 2003) (2015) 45, 2 515-524
a=11.6372(11)Å b=7.5691(6)Å c=21.511(2)Å
α=90.00° β=94.403(3)° γ=90.00°
2(C46H42BrCuN10O2),(Br4Cu2)
2(C46H42BrCuN10O2),(Br4Cu2)
Dalton transactions (Cambridge, England : 2003) (2015) 45, 2 515-524
a=20.0008(5)Å b=18.3973(4)Å c=24.6565(7)Å
α=90.00° β=95.0920(10)° γ=90.00°
C25H18Br3Cu2N4O
C25H18Br3Cu2N4O
Dalton transactions (Cambridge, England : 2003) (2015) 45, 2 515-524
a=8.2845(2)Å b=12.2544(3)Å c=24.6190(7)Å
α=90.00° β=92.9230(10)° γ=90.00°
Bis(4-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(pyridin-2-yl)-6-methylpyrimidine)-iron(ii) bis(tetrafluoroborate)
C30H30FeN102,2(BF41)
Dalton transactions (Cambridge, England : 2003) (2015) 45, 1 107-120
a=12.8079(14)Å b=19.1932(19)Å c=27.373(3)Å
α=90° β=90° γ=90°
Bis(4-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(pyridin-2-yl)-6-methylpyrimidine)-iron(ii) bis(tetrafluoroborate) hemi(ethanol hydrate)
C30H30FeN102,2(BF41),0.41(C2H6O),0.4(H2O)
Dalton transactions (Cambridge, England : 2003) (2015) 45, 1 107-120
a=46.241(3)Å b=8.2140(5)Å c=18.5849(10)Å
α=90° β=93.444(4)° γ=90°
Bis(4-(3,5-dimethyl-1H-pyrazol-1-yl)-2-(pyridin-2-yl)-6-methylpyrimidine)-iron(ii) bis(tetrafluoroborate) ethanol hydrate
C30H30FeN102,2(BF41),C2H6O,H2O
Dalton transactions (Cambridge, England : 2003) (2015) 45, 1 107-120
a=16.9811(4)Å b=11.3326(3)Å c=20.1037(6)Å
α=90° β=105.4330(10)° γ=90°
4-(3,5-dimethyl-1H-pyrazol-1-yl)-2-phenyl-pyrimidyne
C16H16N4
Acta Crystallographica Section B (2005) 61, 2 164-173
a=19.499(3)Å b=4.7884(6)Å c=15.106(2)Å
α=90.00° β=90.00° γ=90.00°
(4-(3,5-dimethyl-1H-pyrazol-1-yl)-2-phenyl-pyrimidyne)dichlorocopper(II) green form
C16H16Cl2CuN4
Acta Crystallographica Section B (2005) 61, 2 164-173
a=7.2156(3)Å b=11.6522(4)Å c=20.3956(8)Å
α=90.00° β=99.8410(10)° γ=90.00°
(4-(3,5-dimethyl-1H-pyrazol-1-yl)-2-phenyl-pyrimidyne)dichlorocopper(II) emerald green form
C16H16Cl2CuN4
Acta Crystallographica Section B (2005) 61, 2 164-173
a=11.6899(6)Å b=14.9843(8)Å c=19.2115(9)Å
α=90.00° β=90.00° γ=90.00°
(4-(3,5-dimethyl-1H-pyrazol-1-yl)-2-phenyl-pyrimidyne)dichlorocopper(II) orange form
C16H16Cl2CuN4
Acta Crystallographica Section B (2005) 61, 2 164-173
a=9.7652(6)Å b=18.7631(10)Å c=9.8115(4)Å
α=90.00° β=108.5440(10)° γ=90.00°